C 18 H 13 Cl 2 NO 3 , monoclinic, P21/n (no. 14), a = 13.6464(2) Å,
Source of material
4,5-Dichlorophthalic anhydride (0.54 g, 2.4 mmol) and 4-carbonylmethyl-2,6-dimethylaniline (0.398 g, 2.4 mmol) were mixed in a ask, that was evacuated and lled with nitrogen, then the mixture were dissolved in glacial acetic acid (10 mL) and re uxed for 3 h. The solution was removed under reduced pressure until the volume reached 5 mL. After addition of 10 mL of acetic anhydride, the solution was re uxed again for 20 h. The solvents were evaporated under reduced pressure. 
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The residue was neutralized with a solution of sodium bicarbonate (4%) and stirred for 30 min. The organic phase was extracted with CH 2 Cl 2 and washed with H 2 O (3 * 20 mL), dried (Na 2 SO4), and the solvent was evaporated under reduced pressure. The products were separated by column chromatography (cyclohexane/EtoAc 10:1), yielded the product (0.71 g, 81.98%) as a white solid. Single crystals were grown by slow evaporation from a 3/1 (v/v) solution of CHCl 3 and EtOAc.
Experimental details
All the hydrogen atoms were generated geometrically.
Discussion
The title compound, C 18 H 13 Cl 2 NO 3 , is a product of amidolysis reaction of 4,5-dichlorophthalic anhydride and 4-carbonylmethyl-2,6-dimethylaniline. The asymmetric unit of this structure contains two discrete molecules. In the two independent molecules, the dihedral angles between the substituted phenyl rings and benzofuranyl moieties are 80.00(4) and 76.34(5)°, respectively. Among various classes of receptor molecules, the quinoxaline-bridged resorcin arene are particularly fascinating because of their ability to undergo a triggered conformational transition from a contracted vase state to an expanded kite state [1] . The compound we synthetized can be used to bridge di erent arm molecules with the dicavitand.
